Adenine Base Editing


Journal

GEN biotechnology
ISSN: 2768-1556
Titre abrégé: GEN Biotechnol
Pays: United States
ID NLM: 9918400388506676

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 29 03 2022
accepted: 11 05 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 12 7 2022
Statut: ppublish

Résumé

Base editors (BEs) have opened new avenues for the treatment of genetic diseases. However, advances in delivery approaches are needed to enable disease targeting of a broad range of tissues and cell types. Adeno-associated virus (AAV) vectors remain one of the most promising delivery vehicles for gene therapies. Currently, most BE/guide combinations and their promoters exceed the packaging limit (∼5 kb) of AAVs. Dual-AAV delivery strategies often require high viral doses that impose safety concerns. In this study, we engineered an adenine base editor (ABE) using a compact Cas9 from

Identifiants

pubmed: 35811581
doi: 10.1089/genbio.2022.0015
pii: 10.1089/genbio.2022.0015
pmc: PMC9258002
doi:

Types de publication

Journal Article

Langues

eng

Pagination

285-299

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM125797
Pays : United States

Informations de copyright

Copyright 2022, Mary Ann Liebert, Inc., publishers.

Déclaration de conflit d'intérêts

H.Z., N.B., P.L., X.D.G., S.A.W., W.X., and E.J.S. are coinventors on patent filings related to this study. G.G. is scientific cofounder, scientific advisor, and equity holder of Voyager Therapeutics, Adrenas Therapeutics, and Aspa Therapeutics. E.J.S. is a cofounder, scientific advisor, and equity holder of Intellia Therapeutics, and a member of the scientific advisory board of Tessera Therapeutics.

Références

Mol Ther. 2020 Aug 5;28(8):1753-1755
pubmed: 32710826
Nat Med. 2019 Feb;25(2):229-233
pubmed: 30664785
Nat Biotechnol. 2020 Jul;38(7):824-844
pubmed: 32572269
Mol Ther. 2010 Jan;18(1):80-6
pubmed: 19904234
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5
pubmed: 11209059
Cell Discov. 2019 Aug 20;5:41
pubmed: 31636954
CRISPR J. 2021 Apr;4(2):169-177
pubmed: 33876959
Hepatology. 2010 Apr;51(4):1200-8
pubmed: 20162619
Hum Mutat. 2017 Aug;38(8):922-931
pubmed: 28544139
Cell. 2017 Jan 12;168(1-2):150-158.e10
pubmed: 28041849
Nat Biomed Eng. 2021 Feb;5(2):179-189
pubmed: 33495639
Nature. 2015 Apr 9;520(7546):186-91
pubmed: 25830891
Cells. 2020 Jul 27;9(8):
pubmed: 32727031
Nat Rev Drug Discov. 2019 May;18(5):358-378
pubmed: 30710128
Nat Commun. 2021 Apr 9;12(1):2121
pubmed: 33837189
Nat Commun. 2020 Nov 17;11(1):5827
pubmed: 33203850
Nat Biomed Eng. 2020 Jan;4(1):125-130
pubmed: 31740768
Cell Death Dis. 2017 May 18;8(5):e2805
pubmed: 28518148
Hum Gene Ther. 2020 Apr;31(7-8):398-399
pubmed: 32302233
Lancet. 1992 Oct 3;340(8823):813-7
pubmed: 1383656
Mol Ther. 2020 Apr 8;28(4):1177-1189
pubmed: 31991108
Nat Biotechnol. 2018 Sep;36(8):717-725
pubmed: 29985478
CRISPR J. 2019 Feb;2(1):23-30
pubmed: 31021234
Hum Gene Ther. 1999 Jul 1;10(10):1735-7
pubmed: 10428218
Nat Biomed Eng. 2021 Feb;5(2):169-178
pubmed: 33077938
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nat Biotechnol. 2016 Mar;34(3):328-33
pubmed: 26829318
Mol Ther. 2022 Jan 5;30(1):164-174
pubmed: 33992807
Nat Biotechnol. 2020 Aug;38(8):910
pubmed: 32760031
Nat Biotechnol. 2018 Oct;36(9):843-846
pubmed: 29813047
Nat Commun. 2019 Jan 25;10(1):439
pubmed: 30683865
Mol Cell. 2019 Dec 19;76(6):938-952.e5
pubmed: 31668930
Sci Transl Med. 2022 Mar 16;14(636):eabl9238
pubmed: 35294257
Cell. 2017 Sep 7;170(6):1224-1233.e15
pubmed: 28844692
Hum Gene Ther. 2018 Mar;29(3):285-298
pubmed: 29378426
Nucleic Acids Res. 2019 Jul 26;47(13):e75
pubmed: 30982889
Nat Commun. 2020 Apr 24;11(1):1979
pubmed: 32332735
Nat Biomed Eng. 2022 Feb;6(2):181-194
pubmed: 34446856
Sci Transl Med. 2020 Jun 3;12(546):
pubmed: 32493795
Nature. 2017 Nov 23;551(7681):464-471
pubmed: 29160308
Sci China Life Sci. 2021 Aug;64(8):1355-1367
pubmed: 33420918
Nat Commun. 2017 Jun 06;8:15790
pubmed: 28585549
Biochem Biophys Res Commun. 2018 Jul 7;502(1):116-122
pubmed: 29787760
Mol Cell. 2019 Feb 21;73(4):714-726.e4
pubmed: 30581144
Cell. 2016 Dec 15;167(7):1829-1838.e9
pubmed: 27984730
Nat Cell Biol. 2021 May;23(5):552-563
pubmed: 33972728
Hum Mol Genet. 2000 May 22;9(9):1377-84
pubmed: 10814719
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29691-29701
pubmed: 33148801
Nat Commun. 2020 Nov 27;11(1):6073
pubmed: 33247095
Sci Rep. 2016 Jun 21;6:28295
pubmed: 27323888
Sci Adv. 2017 Jul 12;3(7):e1701620
pubmed: 28706995
Nat Biotechnol. 2020 Jul;38(7):883-891
pubmed: 32433547
Hum Gene Ther. 2020 Jul;31(13-14):695-696
pubmed: 32605399
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
iScience. 2020 Jan 24;23(1):100764
pubmed: 31887661
Nat Biotechnol. 2019 Mar;37(3):224-226
pubmed: 30809026
Nat Rev Genet. 2018 Dec;19(12):770-788
pubmed: 30323312
Nat Commun. 2021 Nov 1;12(1):6267
pubmed: 34725353
Nat Biotechnol. 2014 Jun;32(6):551-3
pubmed: 24681508
Nat Biomed Eng. 2020 Jan;4(1):97-110
pubmed: 31937940
Protein Cell. 2019 Sep;10(9):700
pubmed: 31087276
Nature. 2021 Jan;589(7843):608-614
pubmed: 33408413
Nat Biotechnol. 2019 Aug;37(8):884-894
pubmed: 31375812
Plant Biotechnol J. 2019 Feb;17(2):499-504
pubmed: 30051586
Nat Med. 2018 Oct;24(10):1519-1525
pubmed: 30297904
Nat Biotechnol. 2019 Jun;37(6):626-631
pubmed: 31110355
mBio. 2018 Dec 4;9(6):
pubmed: 30514786
Mol Ther. 2022 Jan 5;30(1):283-294
pubmed: 34298129
CRISPR J. 2020 Aug;3(4):276-283
pubmed: 32833533
Nat Biotechnol. 2021 Aug;39(8):949-957
pubmed: 34012094
Nature. 2021 May;593(7859):429-434
pubmed: 34012082
Sci Adv. 2021 Apr 30;7(18):
pubmed: 33931459
Mol Ther. 2021 Nov 3;29(11):3107-3124
pubmed: 34509669
Nat Biotechnol. 2020 Jul;38(7):892-900
pubmed: 32284586
Nat Biotechnol. 2017 May;35(5):475-480
pubmed: 28398345
Plant Biotechnol J. 2022 Feb;20(2):350-359
pubmed: 34582079
Nat Commun. 2020 Sep 25;11(1):4871
pubmed: 32978399
Nat Rev Genet. 2015 May;16(5):261-75
pubmed: 25732612
Gene Ther. 2020 Sep;27(9):451-458
pubmed: 32203198
Hum Gene Ther. 1996 Nov 10;7(17):2101-12
pubmed: 8934224
Cold Spring Harb Protoc. 2020 Aug 3;2020(8):095513
pubmed: 32457039
Signal Transduct Target Ther. 2019 Sep 20;4:36
pubmed: 31637015
RNA. 2019 Nov;25(11):1421-1431
pubmed: 31439808
Nat Biotechnol. 2018 Jul;36(6):536-539
pubmed: 29702637
Cell. 2020 Apr 2;181(1):136-150
pubmed: 32243786
Genome Biol. 2018 Sep 19;19(1):137
pubmed: 30231914

Auteurs

Han Zhang (H)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Nathan Bamidele (N)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Pengpeng Liu (P)

Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Ogooluwa Ojelabi (O)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Xin D Gao (XD)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Tomás Rodriguez (T)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Haoyang Cheng (H)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Karen Kelly (K)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Jonathan K Watts (JK)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Departments of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
NeuroNexus Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Jun Xie (J)

Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Viral Vector Core, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Departments of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA..
Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Guangping Gao (G)

Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Viral Vector Core, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Departments of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA..
Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Scot A Wolfe (SA)

Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Wen Xue (W)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Departments of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Erik J Sontheimer (EJ)

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Classifications MeSH